Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion

Endocrinology

Volumn 147, Issue 8, 2006, Pages 3936-3942

  Ren, Song Guang ^a   Melmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; PROTEIN BCL 2; PYRIDOXAL 5 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HORMONE RELEASE; HYPOPHYSIS CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT;

ADENOMA; ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; G1 PHASE; GROWTH HORMONE; MICE; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTIN; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIDOXAL PHOSPHATE; RATS; RATS, SPRAGUE-DAWLEY; S PHASE; VITAMIN B COMPLEX;

EID: 33746079198     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1219     Document Type: Article

References (49)

1. 6. In: Rucker RB, Suttie JW, McCormick DB, Machlin LJ, eds. Handbook of vitamins. 3rd ed. New York: Marcel Dekker; 339-396
2. Talbott MC, Miller LT, Kerkvliet NI 1987 Pyridoxine supplementation: effect on lymphocyte responses in elderly persons. Am J Clin Nutr 46:659-664
3. 6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily. J Biol Chem 267:3819-3824
4. 12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95:373-380
5. Gridley DS, Stickney DR, Shultz TD 1989 Evaluation of cancer patient leukocyte responses in the presence of physiologic and pharmacologic pyridoxine and pyridoxal levels. J Clin Lab Anal 3:95-100
6. 6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 97:684-692
7. Kamat AM, Lamm DL 2002 Chemoprevention of bladder cancer. Urol Clin North Am 29:157-168
8. Bidoli E, Bosetti C, La Vecchia C, Levi F, Parpinel M, Talami R, Negri E, Maso LD, Franceschi S 2003 Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case-control study. Cancer Causes Control 14:477-484
9. 6 suppress growth and expression of albumin gene in a human hepatoma cell line HepG2. Nutr Cancer 28:206-211
10. Shultz TD, Santamaria AG, Gridley DS, Stickney DR, Slater JM 1988 Effect of pyridoxine and pyridoxal on the in vitro growth of huamn malignant melanoma. Anticancer Res 8:1313-1318
11. 6. Nutr Cancer 7:43-52
12. 6 on cell divisions. J Inorg Biochem 17:185-203
13. Reiter EO, Root AW 1978 Effect of pyridoxine on pituitary release of growth hormone and prolactin in childhood and adolescence. J Clin Endocrinol Metab 47:689-690
14. Delitala G, Masala A, Alagna S, Devilla L 1976 Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway. J Clin Endocrinol Metab 42:603-606
15. Delitala G, Meloni T, Masala A, Alagna S, Devilla L, Costa R 1978 Action of somatostatin, levodopa and pyridoxine on growth hormone (GH) secretion in newborn infants. Biomedicine 29:13-15
16. Peters F, Zimmermann G, Breekwoldt M 1978 Effect of pyridoxine on plasma levels of HGH, PRL, and TSH in normal women. Acta Endocrinol 89:217-220
17. 6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes. J Clin Endocrinol Metab 44:1197-1199
18. Kidd GS, Dimond R, Kark JA, Whorton N, Vigersky RA 1982 The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes. J Clin Endocrinol Metab 54:872-875
19. Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S 1997 Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. J Clin Invest 100:2386-2392
20. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures: differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99:789-798
21. Ren SG, Seliktar J, Li X, Braunstein GD, Melmed S 1998 Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. J Clin Endocrinol Metab 83:1275-1283
22. 6 deficient rats. J Steroid Biochem 25:359-365
23. 6 influences glucocorticoid receptor-dependent gene. J Biol Chem 265:12424-12433
24. Davis BA, Cowing BE 2000 Pyridoxal supplementation reduced cell proliferation and DNA synthesis in estrogen-dependent and -independent mammary carcinoma cell lines. Nutr Cancer 38:281-286
25. 4 pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142:3756-3763
26. 12, and homocysteine. Cancer Epidemiol Biomarkers Prev 12:1271-1272
27. Fairfield KM, Fletcher RH 2002 Vitamins of chronic disease prevention in adults: scientific review. JAMA 287:3116-3126
28. Zhu BT 2003 Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer. Int J Oncol 22:499-508
29. Harnack L, Jacobs Jr DR, Nicodemus K, Lazovich D, Anderson K, Folsom AR 2002 Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer 43:152-158
30. Tucker KL, Olson B, Bakun P, Dallal GE, Selhub J, Rosenberg IH 2004 Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial. Am J Clin Nutr 79:805-811
31. Iciek MB, Rokita HB, Wlodek LB 2001 Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2). Neoplasma 48:307-312
32. 6 status is positively related to lymphocyte proliferation in young women consuming a controlled diet. J Nutr 132:3308-3313
33. Matsubara K, Mori M, Akagi R, Kato N 2004 Anti-angiogenic effect of pyridoxal 5′-phosphate, pyridoxal and pyridoxamine on embryoid bodies derived from mouse embryonic stem cells. Int J Mol Med 14:819-823
34. 6 and its mechanisms. Biochim Biophys Acta 1647:127-130
35. Melmed S, Yamashita S, Yamasaki H, Fagin J, Namba H, Yamamoto H, Weber M, Morita S, Webster J, Prager D 1996 IGF-I receptor signalling: lessons from the somatotroph. Recent Prog Horm Res 51:189-215
36. Ray D, Melmed S 1997 Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228
37. 6) suppresses the rise in prolactin and increases the rise in growth hormone induced by exercise. N Engl J Med 306:477-479
38. 6) decreases opioids-induced hyperprolactinemia. Horm Metabol Res 17:46-47
39. Mims RB, Scott CL, Modebe O, Bethine JE 1975 Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine. J Clin Endocrinol Metab 40:256-259
40. Delitala G, Masala A 1977 Dissociation of growth hormone and prolactin response to levodopa during pyridoxal administration. Biomedicine 27:219-222
41. 6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions. J Endocrinol Invest 2:117-124
42. 6 metabolism. J Clin Invest 66:688-695
43. Schaeffer MC, Gretz D, Mahuren JD, Coburn SP 1995 Tissue B-6 vitamer concentrations in rats fed excess vitamin B-6. J Nutr 125:2370-2378
44. Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ 1983 Sensory neuropathy from pyridoxine abuse, a new megavitamin syndrome. N Engl J Med 309:445-448
45. Parry GJ, Bredesen DE 1985 Sensory neuropathy with low-dose pyridoxine. Neurology 35:1466-1468
46. Shultz TD, Lee D, Stickney DR, Gridley DS 1989 Effect of pyridoxine and pyridoxal on the in vitro growth of human and murine cancer cells. Nutr Res 9:133-151
47. Komatsu SI, Watannabe H, Oka Tatsuzo, Tsuge H, Nii H, Kato N 2001 Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 131:2204-2207
48. 6 in BALB/c mice. J Natl Cancer Inst 78:951-959
49. 6 on colon cell proliferation in mice. Oncol Rep 14:265-269